Sign in
Taking peopleNo phase

Preoperative and Postoperative Radiosurgery in Patients With Brain Metastases Undergoing Surgery

Key facts

Who runs it
Fundacion Miguel Servet
Where
Spain5 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
50 people, planned
Started
30 Sept 2026
Expected to end
31 Mar 2030
Type of study
Interventional, 2 groups
Treatments tested
  • SRS
  • metastasectomy: surgical resection
Record updated
18 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age ≥18 years
  • Histologically confirmed solid tumor with one to four brain metastases
  • At least one brain metastasis considered suitable for surgical resection and stereotactic radiosurgery
  • Karnofsky Performance Status (KPS) ≥70
  • Life expectancy ≥3 months
  • Ability to undergo MRI examinations
  • Written informed consent provided

Who cannot take part

  • Prior radiotherapy to the index lesion
  • Contraindication to surgery or stereotactic radiosurgery
  • Brain metastases from small-cell lung cancer, germ cell tumors, lymphoma, or leukemia
  • Leptomeningeal disease at baseline
  • Any condition that, in the investigator's opinion, would interfere with study participation or evaluation
  • Pregnancy or breastfeeding

This trial is currently available in Spain.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The PREOP-RAD study aims to evaluate the feasibility, safety, and efficacy of preoperative surgical resection (SRS) in patients with large brain metastases requiring surgical resection, taking into account potential differences based on sex/gender, compared to postoperative SRS, within the Spanish healthcare context.

Read full original descriptionShow less

More specifically, the study seeks to:

* Assess the clinical and radiological outcomes of the preoperative strategy in terms of local control, progression-free survival, and the occurrence of radionecrosis or neuromuscular dysfunction (nMD) compared to the postoperative strategy. * Study the histopathological profile of resected lesions before and after SRS, searching for personalized biomarkers of response and toxicity. * Identify patterns based on radiomic analysis and advanced imaging related to therapeutic response, recurrence, and complications.

PREOP-RAD is a prospective, randomized, multicenter study that will include patients diagnosed with symptomatic, single or multiple brain metastases ≥2 cm who are candidates for surgical resection. The procedure will consist of preoperative administration of SRS (1-5 fractions, depending on location and size), followed by surgery within a maximum of 10 days.

The intervention will be carried out in coordination with the Neurosurgery and Radiation Oncology Departments of each participating center, using a standardized workflow. The collection of surgical samples will allow for centralized histopathological studies. Furthermore, pre- and postoperative images will undergo radiomic analysis using artificial intelligence tools to explore similarities and correlate morphological and textural characteristics with clinical outcomes.

The 2 groups in the trial

  • preoperative radiosurgeryTreatment being tested

    preoperative radiosurgery (SRS) in patients with brain metastases who are candidates for surgery

    Treatment: SRS and metastasectomy: surgical resection

  • postoperative radiosurgeryOther group

    standard treatment, consisting of surgical resection followed by irradiation of the tumor bed

    Treatment: SRS and metastasectomy: surgical resection

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Randomized Phase II/III Study Comparing Preoperative Radiosurgery Versus Postoperative Radiosurgery in Patients With Brain Metastases Eligible for Surgery: Correlation With Histopathological Factors and Radiomic Analysis.
Record updated
18 November 2026